PHARMACOKINETIC INTERACTION STUDY BETWEEN CLOPIDOGREL AND PHENYTOIN IN HEALTHY MALE RABBITS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 5
Abstract
Introduction: This study was conducted to investigate the effect of clopidogrel – CYP2 C19 inhibitor on the pharmacokinetics (PK) of phenytoin in healthy male rabbits. The main aim of this study is to determine the PK of phenytoin after its daily oral administration when concomitantly administered with cytochrome CYP2 C19 inhibitor clopidogrel. Methodology: An in-vivo parallel designed drug-drug interaction (DDI) study was conducted in healthy male rabbits. Twelve rabbits were divided into two groups. The first group (The control group) received phenytoin of 30 mg/Kg/day for 14 days. On the day fourteen, blood samples were collected according to the time schedule 0.0, 1.30, 3.0, 4.30, 6.0, 7.30, 9.0, 12.0, 24.0, 36.0 and 48.0 hours (h) after the last dose. Chemiluminescent enzyme immunoassay (CLEIA) was used to measure phenytoin concentration in serum. The second group (The tested group) received phenytoin of 30 mg/Kg/day for seven constitutive days and at day 8 clopidogrel of 1.1 mg/Kg/day was added to the phenytoin until the day fourteen, then blood samples were collected as in the first group at the same time schedule for 48 h. Non-compartmental analysis by using winnonlin was used to determine the different PK parameters such as Cmax, Tmax, AUC0-48, t1/2 and ke. Results: Significant increase were reported in the second group related to first group in Cmax, AUC 0-48 and t1/2. In the first group the parameters were: Cmax=11.15μg/ ml and AUC 0-48=174.09 μg.h/ml. In the second group the last parameters increased significantly to: Cmax=11.66 μg/ ml, AUC 0-48=198.1 μg.h/ml and significant decrease was also reported in ke. In the first group ke=0.029 h-1 and decreased to ke=0.0185h-1 in the second group. The values of t1/2 were increased from t1/2 = 25.63 h in the first group to 36.51 h in the second group. There was insignificant change in Tmax. Conclusion: Clopidogrel alters the PK parameters of phenytoin to a significant levels.
Authors and Affiliations
Issam Abushammala
Keywords
Related Articles
- EP ID EP618156
- DOI -
- Views 148
- Downloads 0
FORMULATION, PHYSICOCHEMICAL CHARACTERIZATION AND IN VITRO EVALUATION OF WATER-IN-OIL MICROEMULSION CONTAINING VITAMIN E FOR TOPICAL APPLICATION
Vitamin E is an antioxidant agent with low aqueous solubility and bioavailability which has been used to protects the skin from atopic dermatitis and various deleterious effects due to solar radiation by acting as a free...
BIOEQUIVALENCE STUDY OF TWO ORAL OXYTETRACYCLINE FORMULATIONS (OXYTETRACYCLINE 50%® AND TETRAMED®) IN BROILER CHICKENS
The present study was designed to assess the comparative bio-equivalence of Oxytetracycline 50%® and Tetramed® in healthy broiler chickens after oral administration of both products in a dose of 20 mg oxytetracycline/kg....
ORAL GLUCOSE TOLERANCE TESTS WITH COMBINATION OF METHANOLIC EXTRACT OF AERIAL PARTS OF Bulbophyllum neilgherrense AND GLIBENCLAMIDE
Background: Bulbophyllum neilgherrense Wight is an epiphytic monocot belonging to the Orchidaceae family and found in Bangladesh and India. Since orchids have always been used in indigenous medicines, it was therefore of...
EVALUATION OF STANDARD TREATMENT PROTOCOLS OF DIABETESMELLITUS IN A PRIVATE TEACHING HOSPITAL MIRPUR AJK
Diabetes is a metabolic disorder characterized by elevation of blood glucose by a relative absolute deficiency of insulin. This report is based on clinical pharmacy clerkship conducted during March to August 2014 in Medi...
REPLACEMENT OF SOME PLANT PROTEIN SOURCES BY SUNFLOWER CAKE WITH OR WITHOUT ENZYME ON BROILER DIETS
Total of two hundred and ten unsexed commercial chicks were used in this experiment to evaluate the effect of feeding different levels of sunflower meal (SFM) with and without dietary enzyme on performance of broiler chi...